肝细胞癌：手术治疗与不断发展的治疗策略。
Hepatocellular Carcinoma: Surgical Management and Evolving Therapies.
机构信息
Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Huntsman Cancer Center, University of Utah Eccles School of Medicine, Salt Lake City, UT, USA.
出版信息
Cancer Treat Res. 2024;192:185-206. doi: 10.1007/978-3-031-61238-1_10.
Hepatocellular carcinoma (HCC) is the fifth most common cancer in men and the eighth most common cancer in women worldwide. It is also the second leading cause of cancer death worldwide, with 780,000 deaths in 2018. Seventy-two percent of HCC cases occur in Asia, 10% in Europe, 8% in Africa, 5% in North America, and 5% in Latin America (Singal et al. in J Hepatol 72(2):250-261, 2020 [1]).
肝细胞癌（HCC）是全球男性中第五大常见癌症，女性中第八大常见癌症。它也是全球癌症死亡的第二大主要原因，2018 年有 78 万人死亡。72%的 HCC 病例发生在亚洲，10%发生在欧洲，8%发生在非洲，5%发生在北美，5%发生在拉丁美洲（Singal 等人，发表于《肝脏病学》72（2）：250-261，2020 [1]）。
Zotero 插件